CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?
NCT07070934
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Newly Diagnosed
Interventions
BIOLOGICAL:
CAR-T
BIOLOGICAL:
ASCT
Sponsor
Xuzhou Medical University